Main > ONCOLOGY (**) > Ovarian Cancer Pt-Sensitive R *** > Treatment > SE. O. PacliTaxel Inj.+Carboplatin
SE. O. PacliTaxel Inj.+Carboplatin's subsections
(*) DK; FI & SE Launch: 2020. 01.30
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2020. 03.24.
PR Web-Site (DK; FI & SE)
TradeMark
SE. O. PacliTaxel Inj.+Carboplatin's products
This section has no products